GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by River Road Asset Management LLC

River Road Asset Management LLC increased its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 439.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 462,660 shares of the company's stock after buying an additional 376,958 shares during the quarter. River Road Asset Management LLC owned 0.10% of GE HealthCare Technologies worth $35,773,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in GEHC. Vanguard Group Inc. grew its stake in GE HealthCare Technologies by 14.7% during the 3rd quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company's stock valued at $3,029,917,000 after purchasing an additional 5,693,244 shares during the last quarter. Invesco Ltd. lifted its holdings in shares of GE HealthCare Technologies by 21.4% in the 3rd quarter. Invesco Ltd. now owns 5,048,262 shares of the company's stock valued at $343,484,000 after buying an additional 889,297 shares during the period. Bank of New York Mellon Corp lifted its holdings in shares of GE HealthCare Technologies by 7.8% in the 3rd quarter. Bank of New York Mellon Corp now owns 4,380,408 shares of the company's stock valued at $298,043,000 after buying an additional 315,808 shares during the period. Northern Trust Corp lifted its holdings in shares of GE HealthCare Technologies by 8.9% in the 3rd quarter. Northern Trust Corp now owns 4,205,506 shares of the company's stock valued at $286,143,000 after buying an additional 342,040 shares during the period. Finally, Gates Capital Management Inc. lifted its holdings in shares of GE HealthCare Technologies by 17.5% in the 3rd quarter. Gates Capital Management Inc. now owns 2,708,835 shares of the company's stock valued at $184,309,000 after buying an additional 402,900 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

GEHC has been the subject of several analyst reports. Argus boosted their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a "buy" rating in a report on Monday, April 1st. Evercore ISI upped their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an "outperform" rating in a report on Thursday, April 4th. Morgan Stanley upped their price target on GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an "equal weight" rating in a report on Monday, February 12th. Citigroup upped their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a "buy" rating in a report on Wednesday, April 3rd. Finally, UBS Group raised GE HealthCare Technologies from a "sell" rating to a "neutral" rating and upped their price target for the stock from $66.00 to $88.00 in a report on Monday, February 12th. Four research analysts have rated the stock with a hold rating and eight have given a buy rating to the company's stock. Based on data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of "Moderate Buy" and an average price target of $95.08.

GE HealthCare Technologies Price Performance

Shares of GEHC stock traded down $0.69 during trading hours on Wednesday, reaching $85.19. The company had a trading volume of 1,711,343 shares, compared to its average volume of 3,432,868. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.83 and a current ratio of 1.05. The stock has a fifty day moving average of $88.61 and a 200-day moving average of $77.65. The company has a market capitalization of $38.87 billion, a price-to-earnings ratio of 28.21, a PEG ratio of 3.00 and a beta of 0.94. GE HealthCare Technologies Inc. has a 12-month low of $62.35 and a 12-month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.07 by $0.11. The business had revenue of $5.20 billion during the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a return on equity of 25.58% and a net margin of 8.02%. The business's revenue was up 5.3% compared to the same quarter last year. During the same period in the prior year, the business earned $1.31 earnings per share. On average, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a $0.03 dividend. The ex-dividend date is Thursday, April 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.97%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.